European Journal of Cancer
Volume 38, Supplement 8 , Pages S19-S24, December 2002

Phase II trial of ZD0473 as second-line therapy in mesothelioma

  • G Giaccone

      Affiliations

    • Free University Hospital, Amsterdam, The Netherlands
    • Tel.: +31 20 4444 352; Fax: +31 20 4444 079.
    • ,
  • M.E.R O'Brien

      Affiliations

    • Royal Marsden Hospital, Sutton, UK
    • Kent Cancer Centre, Maidstone, UK
    • ,
  • M.J Byrne

      Affiliations

    • Sir Charles Gairdner Hospital, Nedlands, Australia
    • ,
  • M Bard

      Affiliations

    • Institut Gustave Roussy, Villejuif, France
    • ,
  • E Kaukel

      Affiliations

    • Allgemeines Krankenhaus Harburg, Hamburg, Germany
    • ,
  • B Smit

      Affiliations

    • Tygerberg Hospital, Tygerberg, South Africa

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(02)80018-1

European Journal of Cancer
Volume 38, Supplement 8 , Pages S19-S24, December 2002

Article Tools